TLR9 triggers MyD88-independent anti-inflammatory signaling in lupus
Trends in Immunology · 2023
DOI: 10.1016/j.it.2023.01.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Trends in Immunology, 2023. Verfasst von Shikun Zhang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Institute of Basic Medical Sciences, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China. Hauptthemen laut MEDLINE: Toll-Like Receptor 9, Myeloid Differentiation Factor 88. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 10 Literaturangaben. Gefördert von: Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, Institute of Basic Medical Sciences, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
- Department of Immunology, Institute of Basic Medical Sciences, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China; Institute of Immunology, College of Life Sciences, Nankai University, Tia…
Förderung
- Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences
Zitieren
APA
Zhang, S., & Cao, X. (2023). TLR9 triggers MyD88-independent anti-inflammatory signaling in lupus. Trends in Immunology. https://doi.org/10.1016/j.it.2023.01.008
Vancouver
Zhang S, Cao X. TLR9 triggers MyD88-independent anti-inflammatory signaling in lupus. Trends in Immunology. 2023. doi:10.1016/j.it.2023.01.008
BibTeX
@article{Zhang2023,
author = {Zhang, Shikun and Cao, Xuetao},
title = {TLR9 triggers MyD88-independent anti-inflammatory signaling in lupus},
journal = {Trends in Immunology},
year = {2023},
doi = {10.1016/j.it.2023.01.008}
}
EUVIMED